Business

AllPennyStocks.com Announces July 27th to July 31st Canadian Penny Stocks 2 Watch (KBG.V, TLN.TO)

AllPennyStocks.com Announces July 27th to July 31st Canadian Penny Stocks 2 Watch (KBG.V, TLN.TO)

articleLion Rock Resources IncJuly 24, 20093/company/lion-rock-resources-inc/news/allpennystockscom-announces-july-27th-to-july-31st-canadian-penny-stocks-2-watch-kbgv-tlnto
AllPennyStocks.com Announces July 27th to July 31st Canadian Penny Stocks 2 Watch (KBG.V, TLN.TO)

About this update from Lion Rock Resources Inc

[{"type":"text","content":"\nAllPennyStocks.com Announces July 27th to July 31st Canadian Penny Stocks 2 Watch (KBG.V, TLN.TO)\n\n\n Jul. 24, 2009 (Baystreet.ca) -- \nMISSISSAUGA, ON, July 24, 2009 -- AllPennyStocks.com\nMedia, Inc. (http://www.AllPennyStocks.com), a leading penny\nstock / small-cap information site, released its July 27th to July 31st, 2009\nCanadian Penny Stocks to Watch.\n\nCanadian Penny Stocks to Watch:\nKing's Bay Gold Corp. (TSX-Venture: KBG)\nKing's Bay Gold is unique in the industry in that it\nowns most of the equipment required to carry out the various phases of\nexploration. The Corporation is a very active Canadian mineral exploration\ncompany with mineral projects located in Canada's main gold camp - Red Lake,\nON. Strategic properties include - (1) The Headway, a property located in Red\nLake, ON (exploring for gold); (2) The Bobjo Mine, a past producing gold mine\n(exploring for gold and rare earth elements); (3) The Fort Frances property (exploring\nfor PGEs and diamonds); and; (4) the relatively new Phyllis Lake property\n(exploring for rare earth elements).\nThallion Pharmaceuticals Inc. (TSX: TLN)\nThallion Pharmaceuticals Inc. is a biotechnology\ncompany developing pharmaceutical products in the areas of oncology and\ninfectious disease. Thallion has three clinical programs at the Phase II stage\nof development. The two oncology product candidates include TLN-4601, a novel\nanti-cancer therapy targeting the RAS-MAPK pathway, and TLN-232. TLN-4601 is\ncurrently recruiting patients in a multi-centre, Phase II trials in Canada and\nthe United States. Thallion's third product candidate, Shigamabs(R), is a dual\nantibody product for the treatment of Shigatoxin producing E. coli bacterial\ninfections.\nYou can view the Canadian Stocks to Watch in more\ndetail by going here: http://www.allpennystocks.com/aps_ca/stocks2watch/stocks2watch.aspx.\nAbout AllPennyStocks.com Media Inc.:\nAllPennyStocks.com is focused on the small-cap / penny\nstock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US\nsite to provide investors in Canada as well as the United States with\ninformative and unique content and information. AllPennyStocks.com runs weekly penny stocks to watch, has a daily market\nwrite-up, provides company spotlights, runs a unique most active pages strictly\nfor p...

More updates from Lion Rock Resources Inc